Showing results (191-200 of 765) with videos related to

Sort By:
Pageof 77
The Journal of Urology|July 1, 1986
Localized gangrene of the scrotum and penis: a complication of heroin injection into the femoral vesselsW J Somers, F C Lowe
The Journal of Urology|December 1, 1986
Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimensJ I Epstein, J E Oesterling, J C Eggleston, et al.
The Prostate|January 1, 1992
Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrationsW J Glenski, G G Klee, E J Bergstralh, et al.
Urology|July 1, 1995
The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentrationJ M Monda, R P Myers, D G Bostwick, et al.
The Prostate|January 1, 1991
Influence of age, strain, and the testes on rat prostate hormone sensitivityR K Hildebrand, M J Naslund, J E Oesterling, et al.
The Journal of Urology|February 1, 1991
Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parametersF M Chybowski, J J Keller, E J Bergstralh, et al.
The Journal of Urology|June 1, 1989
A new technique of using the in situ appendix as a catheterizable stoma in continent urinary reservoirsM M Issa, J E Oesterling, D A Canning, et al.
Journal of General Internal Medicine|September 1, 1996
Interpreting results of prostate-specific antigen testing for early detection of prostate cancerJ B Meigs, M J Barry, J E Oesterling, et al.
Diagnostic and Therapeutic Endoscopy|January 1, 1994
The use of prosthetic stents in tracheobronchial, gastrointestinal, and genitourinary diseasesE S Edell, R W Hughes, J E Oesterling, et al.
Urology|October 24, 1997
Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin. HYCAT Investigator Group. Hytrin Community Assessment TrialC G Roehrborn, J E Oesterling, P J Olson, et al.
Pageof 77